Baidu
map

山东大学张利宁Circulation Research论文被撤销

2013-04-16 MedSci MedSci原创

    国际学术期刊《循环研究》(Circulation Research)近日发表声明称,应作者要求,该刊撤销了来自中国山东大学等单位的一篇学术论文。      论文的通讯作者是山东大学医学院免疫系教授、博导张利宁,其他作者则包括山东大学副校长、中国工程院院士张运等,分别来自山东大学免疫系、齐鲁医院教育部与卫生部心血管重构与功

    国际学术期刊《循环研究》(Circulation Research)近日发表声明称,应作者要求,该刊撤销了来自中国山东大学等单位的一篇学术论文。 
    论文的通讯作者是山东大学医学院免疫系教授、博导张利宁,其他作者则包括山东大学副校长、中国工程院院士张运等,分别来自山东大学免疫系、齐鲁医院教育部与卫生部心血管重构与功能研究实验室和美国国立卫生研究院牙科和颅面研究所粘膜免疫部。
    撤销声明称,文章在线发表后,图2B和2D中的eIF2a条带、图2D和3A中的 XBP1s条带、图4A和4B中的caspase 3条带出现明显重复。山东大学医学院学术委员会在期刊编辑要求下,进行了调查并确认了这些错误。根据调查结果,作者能够提供这些条带新的原始“点迹”(数 据)支持他们的结论,并认为上述错误是由于数据管理疏忽造成的。
    此外,作者提供给学术委员会的图2C中的p-eIF2a条带和图2D中的p-PERK条带的原始“点迹”类似,但是和论文中所对应的图片却不同。图4b中的CHOP条带的原始点迹则由于丢失不能提供。
    声明最后称,尽管能证明结论,但是意识到上述错误已经影响到论文本身,因此作者要求撤销论文,并对他们的疏忽表示歉意。
    据悉,此前山东大学学者发表在《分子医学期刊》的一篇论文也因图片中“点迹”重复,主动要求撤销,论文的通讯作者为张继东、Huixia Lu和张运(见:山东大学学者因“图片重复”主动撤销《分子医学期刊》发表论文)。


相关资讯:
山东大学学者因“图片重复”主动撤销《分子医学期刊》发表论文
中国研究人员多篇论文被国际期刊撤销
王志国与杨宝峰课题组撤销两篇国际期刊论文

附:

Circulation Research撤销声明(英文)

Notice of Retraction

The authors of the following article, which published Online First on October 9, 2012, have requested that it be retracted from publication in Circulation Research:

Gao Q, Jiang Y, Dai S, Wang B, Gao F, Guo C, Zhu F, Wang Q, Wang X, Wang J, Shi Y, Zhang Y, Chen W, Zhang L. Interleukin 17A exacerbates atherosclerosis by promoting fatty acid-binding protein 4–mediated ER stress in macrophages. Circ Res. October 9, 2012; DOI:10.1161/CIRCRESAHA.112.272567.

After Online First publication, apparent duplication of panels eIF2a in Figure 2B and 2D, XBP1s in Figure 2D and 3A, and caspase 3 in Figure 4A and 4B was discovered. After being informed by the editors of these errors, the authors immediately provided the original blots for these figure panels to the editors. Upon request of the Editors, the Academic Committee of Shandong University School of Medicine conducted an institutional investigation into apparent duplication of at least three figure panels. The investigation confirmed these errors. According to the committee, the authors were able to provide new original blots for these panels that supported their conclusions and attribute these errors to careless management of data. In addition, the original blots of p-eIF2a in Figure 2C and p-PERK in Figure 2D provided to the Committee were similar but not identical to the corresponding figures in the article. As reported to the journal by the committee, the authors could only provide blots with a similar trend for CHOP in Figure 4B because the original blots were missing.

Although the authors stand by their conclusions of the article, they recognize that the errors in the manuscript have affected the impact of the article. Therefore, the authors have requested to retract the article. The authors apologize for their carelessness, and Editors of Circulation Research agree the article warrants retraction in order to correct the literature.


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1487843, encodeId=c72f148e843a2, content=<a href='/topic/show?id=39cd5699947' target=_blank style='color:#2F92EE;'>#撤销#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56999, encryptionId=39cd5699947, topicName=撤销)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94e08379127, createdName=jiafufeng@yaho, createdTime=Thu Apr 18 01:26:00 CST 2013, time=2013-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557707, encodeId=bc54155e70753, content=<a href='/topic/show?id=d2601533982' target=_blank style='color:#2F92EE;'>#Research#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15339, encryptionId=d2601533982, topicName=Research)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96ab14929432, createdName=yangshch, createdTime=Thu Apr 18 01:26:00 CST 2013, time=2013-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5635, encodeId=3f8b563569, content=同意!但是SCI文章作为评价标准能促进水平的提升,但不能为了发文章而发文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=quli, createdTime=Tue Apr 16 18:56:00 CST 2013, time=2013-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5632, encodeId=39c6563231, content=以后会不会影响其他人发表文章?, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=jiangmin, createdTime=Tue Apr 16 13:30:00 CST 2013, time=2013-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5630, encodeId=11a056306e, content=啊~~要引以为戒, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=88gogo, createdTime=Tue Apr 16 11:54:00 CST 2013, time=2013-04-16, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1487843, encodeId=c72f148e843a2, content=<a href='/topic/show?id=39cd5699947' target=_blank style='color:#2F92EE;'>#撤销#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56999, encryptionId=39cd5699947, topicName=撤销)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94e08379127, createdName=jiafufeng@yaho, createdTime=Thu Apr 18 01:26:00 CST 2013, time=2013-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557707, encodeId=bc54155e70753, content=<a href='/topic/show?id=d2601533982' target=_blank style='color:#2F92EE;'>#Research#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15339, encryptionId=d2601533982, topicName=Research)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96ab14929432, createdName=yangshch, createdTime=Thu Apr 18 01:26:00 CST 2013, time=2013-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5635, encodeId=3f8b563569, content=同意!但是SCI文章作为评价标准能促进水平的提升,但不能为了发文章而发文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=quli, createdTime=Tue Apr 16 18:56:00 CST 2013, time=2013-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5632, encodeId=39c6563231, content=以后会不会影响其他人发表文章?, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=jiangmin, createdTime=Tue Apr 16 13:30:00 CST 2013, time=2013-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5630, encodeId=11a056306e, content=啊~~要引以为戒, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=88gogo, createdTime=Tue Apr 16 11:54:00 CST 2013, time=2013-04-16, status=1, ipAttribution=)]
    2013-04-18 yangshch
  3. [GetPortalCommentsPageByObjectIdResponse(id=1487843, encodeId=c72f148e843a2, content=<a href='/topic/show?id=39cd5699947' target=_blank style='color:#2F92EE;'>#撤销#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56999, encryptionId=39cd5699947, topicName=撤销)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94e08379127, createdName=jiafufeng@yaho, createdTime=Thu Apr 18 01:26:00 CST 2013, time=2013-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557707, encodeId=bc54155e70753, content=<a href='/topic/show?id=d2601533982' target=_blank style='color:#2F92EE;'>#Research#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15339, encryptionId=d2601533982, topicName=Research)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96ab14929432, createdName=yangshch, createdTime=Thu Apr 18 01:26:00 CST 2013, time=2013-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5635, encodeId=3f8b563569, content=同意!但是SCI文章作为评价标准能促进水平的提升,但不能为了发文章而发文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=quli, createdTime=Tue Apr 16 18:56:00 CST 2013, time=2013-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5632, encodeId=39c6563231, content=以后会不会影响其他人发表文章?, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=jiangmin, createdTime=Tue Apr 16 13:30:00 CST 2013, time=2013-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5630, encodeId=11a056306e, content=啊~~要引以为戒, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=88gogo, createdTime=Tue Apr 16 11:54:00 CST 2013, time=2013-04-16, status=1, ipAttribution=)]
    2013-04-16 quli

    同意!但是SCI文章作为评价标准能促进水平的提升,但不能为了发文章而发文章

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1487843, encodeId=c72f148e843a2, content=<a href='/topic/show?id=39cd5699947' target=_blank style='color:#2F92EE;'>#撤销#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56999, encryptionId=39cd5699947, topicName=撤销)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94e08379127, createdName=jiafufeng@yaho, createdTime=Thu Apr 18 01:26:00 CST 2013, time=2013-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557707, encodeId=bc54155e70753, content=<a href='/topic/show?id=d2601533982' target=_blank style='color:#2F92EE;'>#Research#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15339, encryptionId=d2601533982, topicName=Research)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96ab14929432, createdName=yangshch, createdTime=Thu Apr 18 01:26:00 CST 2013, time=2013-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5635, encodeId=3f8b563569, content=同意!但是SCI文章作为评价标准能促进水平的提升,但不能为了发文章而发文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=quli, createdTime=Tue Apr 16 18:56:00 CST 2013, time=2013-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5632, encodeId=39c6563231, content=以后会不会影响其他人发表文章?, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=jiangmin, createdTime=Tue Apr 16 13:30:00 CST 2013, time=2013-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5630, encodeId=11a056306e, content=啊~~要引以为戒, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=88gogo, createdTime=Tue Apr 16 11:54:00 CST 2013, time=2013-04-16, status=1, ipAttribution=)]
    2013-04-16 jiangmin

    以后会不会影响其他人发表文章?

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1487843, encodeId=c72f148e843a2, content=<a href='/topic/show?id=39cd5699947' target=_blank style='color:#2F92EE;'>#撤销#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56999, encryptionId=39cd5699947, topicName=撤销)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94e08379127, createdName=jiafufeng@yaho, createdTime=Thu Apr 18 01:26:00 CST 2013, time=2013-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557707, encodeId=bc54155e70753, content=<a href='/topic/show?id=d2601533982' target=_blank style='color:#2F92EE;'>#Research#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15339, encryptionId=d2601533982, topicName=Research)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96ab14929432, createdName=yangshch, createdTime=Thu Apr 18 01:26:00 CST 2013, time=2013-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5635, encodeId=3f8b563569, content=同意!但是SCI文章作为评价标准能促进水平的提升,但不能为了发文章而发文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=quli, createdTime=Tue Apr 16 18:56:00 CST 2013, time=2013-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5632, encodeId=39c6563231, content=以后会不会影响其他人发表文章?, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=jiangmin, createdTime=Tue Apr 16 13:30:00 CST 2013, time=2013-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5630, encodeId=11a056306e, content=啊~~要引以为戒, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=88gogo, createdTime=Tue Apr 16 11:54:00 CST 2013, time=2013-04-16, status=1, ipAttribution=)]
    2013-04-16 88gogo

    啊~~要引以为戒

    0

相关资讯

2012中国科技论文统计结果 临床医学论文最多

根据《中国科技期刊引证报告》结果,2011年,我国科研人员共发表国际论文14.36万篇(未统计港澳地区),排名世界第2,仅次于美国 (41.94万篇)。其中,“表现不俗”的论文(指被引用次数高于国际平均水平)为42927篇,占总数的29.8%,较2010年上升了10个百分点。 其中,生物、临床医学、基础医学、药学等10个学科表现不俗的论文数量最多。表现不俗的论文发表数量排名前5位的医疗机构依次

2012中国百篇更具影响优秀国内学术论文

入选的生物医药类论文如下: 论文题目: 小议在MTT法测细胞增殖抑制率中IC50的计算方法第一作者: 赵斌所属机构: 安徽医科大学来源期刊: 安徽医药,2007,11(09):834-836被引次数: 16 论文题目: 我国中小学生超重肥胖流行现状及其社会经济差异第一作者: 季成叶所属机构: 北京大学来源期刊: 中国学校卫生,2008,29(02):106-108被引次数: 28 论文题目:

医学研究质量决定论文水平

北京协和医院基本外科 蒋朱明  人民卫生出版社 贾晓巍  北京协和医学院出版社 钟紫红  本报记者 耿璐 杨萍 陈惠 日前,在首届“美国- 中国临床营养杂志作者培训工作坊”上,来自中美两国的临床营养专家、编辑专家就“如何选题”、“如何进行临床研究设计”、“如何选择目标期刊”、 “提高文章可读性”、“科研不端与出版伦理”等问题进行了工作坊形式的互动与

学术论文撤稿数十年激增十倍 3/4源自学术不端

    去年《自然》杂志(Nature)报道称,学术论文撤稿数在近十年激增十倍之多,每年撤销的科研论文超过300篇。     部分研究表明,实验差错是大多数论文撤稿的原因,然而在本周发表的一篇文章对论文撤稿进行了更深入的分析,对于这种善意的假设提出了质疑。     这篇研究报道刊登于《美国国家科学院院刊》

Cell : 2012 更佳十二篇文章

正值年末,Cell 发布年终盘点:CELL best  of 2012,罗列了十二篇影响力最大、点击最多的文章,分别如下:1.Resveratrol Ameliorates Aging-Related Metabolic Phenotypes by Inhibiting cAMP Phosphodiesterases Sung-Jun Park, Faiyaz Ahmad, Andre

Nature:高产作者与杂志编辑分享如何撰写论文

作者:Kendall Powell Mark Hauber的学生于2007年向Nature投稿,这是一篇关于捕食一种海鸟的论文,被拒。接着向《科学》杂志投稿,被拒。这位气馁的学生Matt Rayner建议向《Conservation Biology》投稿,这是该研究领域的二类期刊。但是Hauber因为经验丰富,认为这篇论文应该去投更好的杂志。他修改了少许内容,向级别更高的《Proceedings

Baidu
map
Baidu
map
Baidu
map